Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

How To Invest In Cannabis Stocks

Over the last few years, the cannabis sector has been the place to be for stock investors. It is undoubtedly one of the hottest markets around, with a May 2019 report expecting the cannabis market to be worth USD $66.3 billion by 2025 . At the same time, investing in a ...

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...

Opportunity Knocks as the Door Opens to Naturally-Derived Psychedelics

(CLICK IMAGE TO PLAY VIDEO) Stockhouse investors know that investment opportunities are opening up in the burgeoning psychedelics space. And while many are called, few are chosen. One company that looks to be the choice of many in the know is Filament Health Co...

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...

How this Company Plans to Meet the Growing Need for Graphite

The demand for graphite is expected to soar. According to The International Energy Agency, in four years, the world will see around 125 million electric vehicles on the road. Electric vehicles need graphite to produce the anode of lithium-ion batteries. For companies like ...

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...

Novamind’s Trial Site for Merck Another Example Of Its Leadership in Mental Health

Novamind’s clinics and clinical research capabilities are already well established to bring alternative mental health therapies, including psychedelic medicine, to market. One of the world’s largest pharmaceutical companies has selected ...

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...

Medcolcanna Prepares For Recurring Commercial Shipments

An Operational Update for 2021 as The Company Prepares for Recurring Shipments Medcolcanna Organics Inc. (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is providing the following corporate update. Key highlights include: Capacity &...
1 2 3 4 5 6